Preticks
.
Follow Us
News Details
Research Published in Cell Reports Medicine Highlights Potential of Akero Therapeutics' NASH Therapeutic Candidate
About Akero Therapeutics, Inc.
NASDAQ: $AKRO
Notified: $37.75
11:02 EDT
Price Chart